脂氨醇4-酶IIIβ:在高性心肌细胞中治疗收缩功能障碍的治疗标
Myrthe M A Willemars1,2,3, Aomin Sun1,4,5, Shujin Wang1,6
1Department of Genetics & Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands.
International journal of molecular sciences
|January 28, 2026
概括
在心脏缩中抑制酸4-酶IIIβ (PI4KIIIβ) 会减少葡萄糖的吸收,并改善心脏功能,而不会影响细胞大小. 这表明,针对代谢途径,而不仅仅是生长,可以治疗心脏功能障碍.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 代谢研究研究 代谢研究
背景情况:
- 心脏缩是心力衰竭的主要危险因素,其特点是心脏肌肉功能受损.
- 推动过度缩生长和相关的收缩功能障碍的分子机制尚未完全理解.
- 增加葡萄糖摄取量的代谢转变与心脏缩的进展有关.
研究的目的:
- 调查是否抑制氨酸4-酶IIIβ (PI4KIIIβ) 可以逆转高性心肌细胞中增强的葡萄糖吸收.
- 为了确定PI4KIIIβ抑制是否能改善心脏缩引起的收缩功能障碍.
- 评估PI4KIIIβ抑制对高性信号传递,细胞大小和蛋白质合成的影响.
主要方法:
- 通过使用烯 (PE) 或蛋白质激酶D1 (PKD1) 的过度表达,诱导了大鼠和人类心肌细胞的心脏缩.
- 特定的PI4KIIIβ抑制剂MI14用于治疗多变细胞.
- 测量包括mRNA表达 (BNP),高增殖信号,细胞形态,蛋白质合成,葡萄糖吸收和收缩功能.
主要成果:
- 经过PE诱导的过度缩增加了BNP表达,过度缩信号传递,细胞大小,蛋白质合成,葡萄糖吸收和收缩功能受损.
- 治疗MI14可以预防和逆转PE刺激的葡萄糖吸收和收缩功能障碍.
- 抑制PI4KIIIβ并没有影响过敏信号传递,细胞大小或蛋白质合成.
- 在PKD1过度表达模型中观察到对葡萄糖吸收的类似影响.
结论:
- 通过PI4KIIIβ途径准心肌基质代谢,为治疗心脏缩引起的收缩功能障碍提供了一种新的策略.
- 抑制PI4KIIIβ有效地降低了高性心肌细胞中增强的葡萄糖吸收.
- 这种方法解决了功能缺陷,而不改变过度缩生长本身,呈现出一个独特的治疗途径.
相关概念视频
02:54Protein Kinases and Phosphatases
15.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
02:54Protein Kinases and Phosphatases
4.5K
4.5K
02:15The Contractile Ring
7.3K
Contractile rings are composed of microfilaments and are responsible for separating the daughter cells during cytokinesis. Contractile ring assembly proceeds along with other cell cycle events; however, very few mechanistic details are known about the timing and coordination of the contractile rings with the cell cycle.
A small GTPase, RhoA, controls the function and assembly of the contractile ring. RhoA belongs to the Ras superfamily of proteins. The activation of formins by RhoA promotes...
A small GTPase, RhoA, controls the function and assembly of the contractile ring. RhoA belongs to the Ras superfamily of proteins. The activation of formins by RhoA promotes...
7.3K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
467
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
467
01:26Receptor Tyrosine Kinases
18.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.4K
01:13Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K